Study shows white blood cell boosting drugs safe during chemo-radiotherapy of lung cancer

(European Society for Medical Oncology) A late breaking subanalysis of the phase III CONVERT trial presented at the European Lung Cancer Conference (ELCC) shows that white blood cell boosting drugs are safe during concurrent chemo-radiotherapy of small cell lung cancer (SCLC).